Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3903 ARTÍCULOS , VIENDO DEL 2611 AL 2625

Huntington's disease in popular culture: a brief historical perspective

Wexler A.

J Huntingtons Dis. 2014;3(1):1-4. doi: 10.3233/JHD-149002.

Aquatherapy for neurodegenerative disorders

Plecash AR, Leavitt BR.

J Huntingtons Dis. 2014;3(1):5-11. doi: 10.3233/JHD-140010.

Kinase signalling in Huntington's disease

Bowles KR, Jones L.

J Huntingtons Dis. 2014;3(2):89-123. doi: 10.3233/JHD-140106.

Unawareness of deficits in Huntington's disease

Sitek EJ, Thompson JC, Craufurd D, Snowden JS.

J Huntingtons Dis. 2014;3(2):125-35. doi: 10.3233/JHD-140109.

Does interval between screening and baseline matter in HD cognitive clinical trials?

Beglinger LJ, Adams WH, Langbehn D, Fiedorowicz JG, Caviness J, Biglan K, Olson B, Paulsen JS.

J Huntingtons Dis. 2014;3(2):139-44. doi: 10.3233/JHD-140100.

Optimising mobility outcome measures in Huntington's disease

Busse M, Quinn L, Khalil H, McEwan K.

J Huntingtons Dis. 2014;3(2):175-88. doi: 10.3233/JHD-140091.

A pilot study of virtual visits in Huntington disease

Bull MT, Darwin K, Venkataraman V, Wagner J, Beck CA, Dorsey ER, Biglan KM.

J Huntingtons Dis. 2014;3(2):189-95. doi: 10.3233/JHD-140102.

The potential of composite cognitive scores for tracking progression in Huntington's disease

Jones R, Stout JC, Labuschagne I, Say M, Justo D, Coleman A, Dumas EM, Hart E, Owen G, Durr A, Leavitt BR, Roos R, O'Regan A, Langbehn D, Tabrizi SJ, Frost C.

J Huntingtons Dis. 2014;3(2):197-207. doi: 10.3233/JHD-140101.

Ubiquitin pathways in neurodegenerative disease

Atkin G, Paulson H.

Front Mol Neurosci. 2014 Jul 8;7:63. doi: 10.3389/fnmol.2014.00063. eCollection 2014.

The glial response to intracerebrally delivered therapies for neurodegenerative disorders: is this a critical issue?

Cicchetti F, Barker RA.

Front Pharmacol. 2014 Jul 10;5:139. doi: 10.3389/fphar.2014.00139. eCollection 2014.

The potential of epigenetic therapies in neurodegenerative diseases

Coppedè F.

Front Genet. 2014 Jul 14;5:220. doi: 10.3389/fgene.2014.00220. eCollection 2014.

Hypothalamic alterations in Huntington's disease patients: comparison with genetic rodent models

van Wamelen DJ, Aziz NA, Roos RA, Swaab DF.

J Neuroendocrinol. 2014 Nov;26(11):761-75. doi: 10.1111/jne.12190.

Structure prediction of polyglutamine disease proteins: comparison of methods

Wen J, Scoles DR, Facelli JC.

BMC Bioinformatics. 2014;15 Suppl 7(Suppl 7):S11. doi: 10.1186/1471-2105-15-S7-S11. Epub 2014 May 28.

Investigational drugs for the management of Huntington's disease: are we there yet?

Kulkarni P, Saxena U.

Expert Opin Investig Drugs. 2014 Dec;23(12):1595-603. doi: 10.1517/13543784.2014.934807. Epub 2014 Aug 1.

Human striatum remodelling after neurotransplantation in Huntington's disease

Gallina P, Paganini M, Biggeri A, Marini M, Romoli A, Sarchielli E, Berti V, Ghelli E, Guido C, Lombardini L, Mazzanti B, Simonelli P, Peri A, Maggi M, Porfirio B, Di Lorenzo N, Vannelli GB.

Stereotact Funct Neurosurg. 2014;92(4):211-7. doi: 10.1159/000360583. Epub 2014 Jul 30.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias